292 related articles for article (PubMed ID: 26940227)
1. Aspirin use and the risk of cholangiocarcinoma.
Choi J; Ghoz HM; Peeraphatdit T; Baichoo E; Addissie BD; Harmsen WS; Therneau TM; Olson JE; Chaiteerakij R; Roberts LR
Hepatology; 2016 Sep; 64(3):785-96. PubMed ID: 26940227
[TBL] [Abstract][Full Text] [Related]
2. Effects of aspirin and non-steroidal anti-inflammatory drugs on the risk of cholangiocarcinoma: a meta-analysis.
Lapumnuaypol K; Tiu A; Thongprayoon C; Wijarnpreecha K; Ungprasert P; Mao MA; Cheungpasitporn W
QJM; 2019 Jun; 112(6):421-427. PubMed ID: 30753687
[TBL] [Abstract][Full Text] [Related]
3. Proton pump inhibitors and odds of cholangiocarcinoma: A retrospective case-control study.
Xiong J; Wang Y; Xu W; Liu Z; Wang H; Zhang Z; Han Y; Yin C; Cao S; Yang Z; Su T; Wei J; Chen G; Jin L
Liver Int; 2020 Nov; 40(11):2848-2857. PubMed ID: 32910500
[TBL] [Abstract][Full Text] [Related]
4. Risk factors, epidemiology and prognosis of cholangiocarcinoma in Finland.
Barner-Rasmussen N; Pukkala E; Hadkhale K; Färkkilä M
United European Gastroenterol J; 2021 Dec; 9(10):1128-1135. PubMed ID: 34533900
[TBL] [Abstract][Full Text] [Related]
5. Independent of Primary Sclerosing Cholangitis and Cirrhosis, Early Adulthood Obesity Is Associated with Cholangiocarcinoma.
Hatia RI; Eluri M; Hawk ET; Shalaby A; Karatas E; Shalaby A; Abdelhakeem A; Abdel-Wahab R; Chang P; Rashid A; Jalal PK; Amos CI; Han Y; Armaghany T; Shroff RT; Li D; Javle M; Hassan MM
Cancer Epidemiol Biomarkers Prev; 2023 Oct; 32(10):1338-1347. PubMed ID: 37540502
[TBL] [Abstract][Full Text] [Related]
6. Association between variants in inflammation and cancer-associated genes and risk and survival of cholangiocarcinoma.
Chaiteerakij R; Juran BD; Aboelsoud MM; Harmsen WS; Moser CD; Giama NH; Allotey LK; Mettler TA; Baichoo E; Zhang X; Therneau TM; Lazaridis KN; Roberts LR
Cancer Med; 2015 Oct; 4(10):1599-602. PubMed ID: 26276523
[TBL] [Abstract][Full Text] [Related]
7. Association between praziquantel treatment and cholangiocarcinoma: a hospital-based matched case-control study.
Kamsa-Ard S; Luvira V; Pugkhem A; Luvira V; Thinkhamrop B; Suwanrungruang K; Bhudhisawasdi V
BMC Cancer; 2015 Oct; 15():776. PubMed ID: 26496745
[TBL] [Abstract][Full Text] [Related]
8. Association between Repeated Praziquantel treatment and Papillary, and Intrahepatic Cholangiocarcinoma.
Luvira V; Kamsa-Ard S; Kamsa-Ard S; Luvira V; Srisuk T; Pugkhem A; Pairojkul C; Bhudhisawasdi V
Ann Hepatol; 2018 Aug; 17(5):802-809. PubMed ID: 30145559
[TBL] [Abstract][Full Text] [Related]
9. Incidence and risk factors for cholangiocarcinoma in primary sclerosing cholangitis.
Burak K; Angulo P; Pasha TM; Egan K; Petz J; Lindor KD
Am J Gastroenterol; 2004 Mar; 99(3):523-6. PubMed ID: 15056096
[TBL] [Abstract][Full Text] [Related]
10. Colorectal cancer and cholangiocarcinoma in patients with primary sclerosing cholangitis and inflammatory bowel disease.
Manninen P; Karvonen AL; Laukkarinen J; Aitola P; Huhtala H; Collin P
Scand J Gastroenterol; 2015 Apr; 50(4):423-8. PubMed ID: 25636976
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for intrahepatic cholangiocarcinoma: association between metformin use and reduced cancer risk.
Chaiteerakij R; Yang JD; Harmsen WS; Slettedahl SW; Mettler TA; Fredericksen ZS; Kim WR; Gores GJ; Roberts RO; Olson JE; Therneau TM; Roberts LR
Hepatology; 2013 Feb; 57(2):648-55. PubMed ID: 23055147
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for intrahepatic cholangiocarcinoma in a low-risk population: a nationwide case-control study.
Welzel TM; Mellemkjaer L; Gloria G; Sakoda LC; Hsing AW; El Ghormli L; Olsen JH; McGlynn KA
Int J Cancer; 2007 Feb; 120(3):638-41. PubMed ID: 17109384
[TBL] [Abstract][Full Text] [Related]
13. Cholangiocarcinoma landscape in Europe: Diagnostic, prognostic and therapeutic insights from the ENSCCA Registry.
Izquierdo-Sanchez L; Lamarca A; La Casta A; Buettner S; Utpatel K; Klümpen HJ; Adeva J; Vogel A; Lleo A; Fabris L; Ponz-Sarvise M; Brustia R; Cardinale V; Braconi C; Vidili G; Jamieson NB; Macias RI; Jonas JP; Marzioni M; Hołówko W; Folseraas T; Kupčinskas J; Sparchez Z; Krawczyk M; Krupa Ł; Scripcariu V; Grazi GL; Landa-Magdalena A; Ijzermans JN; Evert K; Erdmann JI; López-López F; Saborowski A; Scheiter A; Santos-Laso A; Carpino G; Andersen JB; Marin JJ; Alvaro D; Bujanda L; Forner A; Valle JW; Koerkamp BG; Banales JM
J Hepatol; 2022 May; 76(5):1109-1121. PubMed ID: 35167909
[TBL] [Abstract][Full Text] [Related]
14. Cholangiocarcinoma in patients with primary sclerosing cholangitis: a multicenter case-control study.
Chalasani N; Baluyut A; Ismail A; Zaman A; Sood G; Ghalib R; McCashland TM; Reddy KR; Zervos X; Anbari MA; Hoen H
Hepatology; 2000 Jan; 31(1):7-11. PubMed ID: 10613720
[TBL] [Abstract][Full Text] [Related]
15. Precancerous bile duct pathology in end-stage primary sclerosing cholangitis, with and without cholangiocarcinoma.
Lewis JT; Talwalkar JA; Rosen CB; Smyrk TC; Abraham SC
Am J Surg Pathol; 2010 Jan; 34(1):27-34. PubMed ID: 19898228
[TBL] [Abstract][Full Text] [Related]
16. Effect of Statins on the Risk of Extrahepatic Cholangiocarcinoma.
Lavu S; Therneau TM; Harmsen WS; Mara KC; Wongjarupong N; Hassan M; Ali HA; Antwi S; Giama NH; Miyabe K; Roberts LR
Hepatology; 2020 Oct; 72(4):1298-1309. PubMed ID: 32119126
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis B virus infection, diabetes mellitus, and their synergism for cholangiocarcinoma development: a case-control study in Korea.
Lee BS; Park EC; Park SW; Nam CM; Roh J
World J Gastroenterol; 2015 Jan; 21(2):502-10. PubMed ID: 25593465
[TBL] [Abstract][Full Text] [Related]
18. Aspirin may prevent cholangiocarcinoma: a case-control study from the United kingdom.
Burr NE; Talboys RJ; Savva S; Clark A; Phillips M; Metcalfe M; Dennison A; Robinson R; Lewis MP; Rhodes M; Rushbrook S; Hart AR
Dig Dis Sci; 2014 Jul; 59(7):1567-72. PubMed ID: 24535250
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a case-control study in China.
Tao LY; He XD; Qu Q; Cai L; Liu W; Zhou L; Zhang SM
Liver Int; 2010 Feb; 30(2):215-21. PubMed ID: 19840244
[TBL] [Abstract][Full Text] [Related]
20. Statins are associated with a reduced risk of cholangiocarcinoma: a population-based case-control study.
Peng YC; Lin CL; Hsu WY; Chang CS; Yeh HZ; Tung CF; Wu YL; Sung FC; Kao CH
Br J Clin Pharmacol; 2015 Oct; 80(4):755-61. PubMed ID: 25808421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
